Effect of Australian propolis from stingless bees (Tetragonula carbonaria) on pre-contracted human and porcine isolated arteries by Massaro, Flavia et al.
Effect of Australian Propolis from Stingless Bees
(Tetragonula carbonaria) on Pre-Contracted Human and
Porcine Isolated Arteries
Flavia C. Massaro, Peter R. Brooks, Helen M. Wallace, Vianne Nsengiyumva, Lorraine Narokai, Fraser D.
Russell*
Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, Maroochydore, Queensland, Australia
Abstract
Bee propolis is a mixture of plant resins and bee secretions. While bioactivity of honeybee propolis has been reported
previously, information is limited on propolis from Australian stingless bees (Tetragonula carbonaria). The aim of this
study was to investigate possible vasomodulatory effects of propolis in KCl-precontracted porcine coronary arteries
using an ex vivo tissue bath assay. Polar extracts of propolis produced a dose-dependent relaxant response
(EC50=44.7±7.0 μg/ml), which was unaffected by endothelial denudation, suggesting a direct effect on smooth
muscle. Propolis markedly attenuated a contractile response to Ca2+ in vessels that were depolarised with 60 mM
KCl, in Ca2+-free Krebs solution. Propolis (160 µg/ml) reduced vascular tone in KCl pre-contracted vessels to near-
baseline levels over 90 min, and this effect was partially reversible with 6h washout. Some loss in membrane
integrity, but no loss in mitochondrial function was detected after 90 min exposure of human cultured umbilical vein
endothelial cells to 160 µg/ml propolis. We conclude that Australian stingless bee (T. carbonaria) propolis relaxes
porcine coronary artery in an endothelial-independent manner that involves inhibition of voltage-gated Ca2+ channels.
This effect is partially and slowly reversible upon washout. Further studies are required to determine the therapeutic
potential of Australian stingless bee propolis for conditions in which vascular supply is compromised.
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Introduction
Bee propolis is a resinous material that bees produce from
plant resins and their body secretions [1]. The chemical
composition of propolis reflects the botanical sources from
which the bees forage [2]. Honeybee (Apis mellifera) propolis
has been more extensively studied than its stingless bee (tribe
Meliponini) counterpart [2]. In a recent study investigating the
chemical composition of New Zealand honeybee and
Australian stingless bee propolis, we identified compounds that
were only present in honeybee propolis (eg. pinocembrin and
galangin), or only present in stingless bee propolis (eg. gallic
acid and pimaric acid) [3]. Various bioactivities have been
ascribed to some of the 300+ compounds present in honeybee
propolis, including antioxidant, antimicrobial, antiinflammatory
and antitumour effects [4-6]. For example, pretreatment of Raw
264.7 cells with an ethanolic extract of propolis inhibited
lipopolysaccharide-stimulated pro-inflammatory signalling
pathways including the phosphorylation of inhibitory protein κB,
c-Jun NH2-terminal kinase 1/2, and p38 mitogen-activated
protein kinase [7]. Synergistic activity by compounds within
propolis is likely [8,9]. For example, antitumour effects were
significantly greater for the water-soluble derivatives than for
the combined effect of the individual polyphenolic compounds
present within ethanolic extracts of Croatian and Brazilian
honeybee propolis [8].
Over the past 5 years, much interest has focussed on the
potential use of propolis for the treatment of injury and disease,
and this has been investigated mainly using animal models or
cell lines. For example propolis and its constituents have been
reported to produce benefits in models of hypertension [10],
wounds [11,12], burns [13], cancer [14] and septic arthritis [15].
The antihypertensive effects of propolis were investigated in
spontaneously hypertensive rat [10], and nitric oxide synthase-
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inhibited rat models of hypertension [16]. Fractions of an
ethanolic extract of propolis from Minas Gerai state in Brazil
reduced blood pressure in the spontaneously hypertensive
rats, with activity ascribed to the flavonoids
dihydrokaempferide, isosakuranetin and betuletol [10]. Propolis
was found to cause vasorelaxation [10,17], and inhibit activity
of the catecholamine-producing enzyme, tyrosine hydroxylase
[16], suggesting possible mechanisms for its blood pressure
lowering effects. The effect of propolis in human hypertension
is not yet known. In the vasculature, honeybee propolis
modulates blood vessel function by stimulating vasorelaxation
[10,17], inhibiting angiogenesis [18,19], and protecting against
atherosclerotic lesion formation [20], raising hopes for the
development of new therapeutics in the treatment of
hypertension, cancer and ischaemic heart disease. These
studies have all used honeybee propolis in their investigations.
We have previously reported on the chemical composition of
propolis from one species of Australian stingless bee
(Tetragonula carbonaria) [3]. We showed in that study that
propolis had antioxidant activity and inhibited 5-lipoxygenase in
cell-free assays. Our study identified the presence of pimaric
acid in propolis [3], whilst another study examining bioactivity of
extracts from roots of Viguiera arenaria found that pimaric acid
relaxes rat thoracic aorta [21]. The bioactivity of Australian
stingless bee propolis in cardiovascular preparations is
presently unknown, and so the aim of this study was to
investigate its potential to modulate vascular tone.
Materials and Methods
Materials
A bulk sample of stingless bee propolis was obtained from
40 hives from within suburban areas of South East
Queensland. T. carbonaria is known to extensively forage on
eucalypt resins, in particular C. torelliana and this species
shapes their chemical ecology [22,23]. After removal of debris
and honey using water, the propolis was unified into a single
homogeneous sample. New Zealand honeybee (A. mellifera)
propolis was obtained from ethanolic tinctures, provided by
Comvita New Zealand. Samples were stored in sealed plastic
containers at 4°C until use.
Gallic acid, NG-nitro-L-arginine methyl ester (L-NAME),
indomethacin, DMSO, ethyl acetate (EtOAc), diethyl ether
(Et2O), rat tail collagen type I, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT)-based in vitro toxicology
assay kit, and lactate dehydrogenase-based toxicology assay
kit were purchased from Sigma-Aldrich (Castle Hill, NSW,
Australia). Pimaric acid reference compound was from Santa
Cruz Biotechnology, CA, USA. Medium 199, Hanks’ Balanced
Salt Solution (HBSS), fetal calf serum, collagenase Type II,
heparin 1A, fungizone antimycotic liquid, Glutamax-I
supplement, and penicillin-streptomycin were purchased from
Invitrogen Australia (Rowville, VIC, Australia). All other
reagents were of analytical grade.
Preparation of propolis
Five extracts of stingless bee propolis were prepared.
Propolis (5% w/v) was extracted by maceration in
hexane:methanol (1:1) for 24h, then paper filtered by gravity. A
portion of the methanol extract was dissolved in diethyl
ether:sodium carbonate (2% saturated) and partitioned into an
ether extract and an aqueous extract. The aqueous extract was
acidified by 0.1 M hydrochloric acid then extracted using ethyl
acetate. The ethanolic extract of stingless bee propolis was
obtained by maceration of raw material in 95% ethanol (5%
w/v) and the solution was paper-filtered by gravity. Commercial
batches of honeybee propolis contained 172 mg/mL of extracts
in 62% ethanol. The five liquid extracts were dried using a
rotary evaporator at 40°C and the dry polar residues were
weighed and reconstituted to 61 mg/mL using 99% DMSO.
These stock solutions were used at the final concentrations
indicated for the bioassays. All samples of propolis used in this
study were chromatographed prior to the bioassays to confirm
their chemical composition. Chemical composition was
determined using gas chromatography-mass spectroscopy
(GC-MS), as previously described [3].
Tissue bath experiments using porcine isolated
coronary artery and human isolated umbilical artery
Pig hearts were collected from a local abattoir and placed
immediately in Krebs’ Henseleit buffer (125 mM Na+, 5 mM K+,
2.25 mM Ca2+, 0.5 mM Mg2+, 98.5 mM Cl-, 0.5 mM SO42-, 32
mM HCO3-, 1 mM HPO42-, 0.04 mM EDTA, 11.7 mM glucose;
pH 7.4), pre-bubbled with 5% CO2 in oxygen, and transported
to the University laboratory on ice. The circumflex coronary
artery was dissected free from the heart and cut into ~1.5 cm
segments using scissors. Vessels were set up in jacketed
tissue baths (37°C) containing 25 ml Krebs’ Henseleit buffer
that was bubbled with 5% CO2 in oxygen. Vessels were
allowed to equilibrate in the baths for 1 h under 40-50 mN
resting tension. During the equilibration period, vessels were
contracted twice with 60 mM KCl followed each time by a
washout with Krebs’ Henseleit solution. Vessels were pre-
contracted with 60 mM KCl and then exposed to a single
concentration of propolis (160 µg/ml), to increasing
concentrations of propolis (0.8-160 µg/ml), or to isovolumetric
solvent (DMSO; ≤0.26% v/v). Following washout, vessels were
contracted with 60 mM KCl, either as a single administration or
as repeat administrations with half-hourly washouts over 6 h.
Some vessels were pre-contracted with 2 mM histamine.
The effect of propolis was also investigated on human
umbilical arteries. Human umbilical cords were obtained from
patients undergoing childbirth via Caesarean section at
Nambour General Hospital with approval from the Human
Research Ethics Committees of the University of the Sunshine
Coast (S/09/221) and Royal Brisbane and Women’s Hospital
(HREC/09/QRBW/184), and Site Specific Assessment approval
from Nambour General Hospital (SSA/09/QNB/22). Arteries
were dissected free at the juncture of the umbilical cord with
the placenta. These vessels were pre-contracted with 60 mM
KCl and then exposed to 160 µg/ml propolis or isovolumetric
DMSO. Developed tension in the blood vessels was recorded
using Powerlab 26T with Chart 5 software (AD Instruments Pty
Ltd, NSW, Australia) and expressed as a percentage of the
initial response to 60 mM KCl.
Vascular Effects of Stingless Bee Propolis
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The role of the endothelium in mediating the relaxant
response to propolis, some vessels were denuded of
endothelial cells by rubbing the lumen with a roughened
metallic probe. Successful endothelial denudation was
determined by visual inspection of 20 µm transverse sections
of vessel cut using a cryostat (Reichert Jung, model 1800) and
stained with hematoxylin and eosin (data not shown).
Endothelial-intact, and endothelial-denuded vessels were
contracted with 60 mM KCl, and then exposed to 40 and 160
μg/ml propolis.
To examine the role of voltage-gated calcium channels in the
relaxant response to propolis, coronary arteries were
equilibrated in Krebs solution for 2h, exposing the tissues to 60
mM KCl to ensure tissue viability. Tissues were then
equilibrated in Ca2+-free Krebs solution containing 0.06 mM
EDTA for 2h, with six replicate sequences involving washout
followed by addition of 60 mM KCl. The final exposure of tissue
to KCl produced a negligible contractile response. Tissues
were then treated with either 160 μg/ml propolis or DMSO
(0.26%) for 30 min in the presence of 60 mM KCl. Without
washout, a concentration-effect curve was constructed to Ca2+
(32 μM-10 mM), before adding the Ca2+ channel inhibitor,
nifedipine (10 μM) to the bath.
Cell viability assays using human cultured umbilical
vein endothelial cells (HUVECs)
Umbilical cords were collected as described above. The
umbilical vein was flushed with Dulbecco’s phosphate buffered
saline to remove blood, and then administered with 1 mg/mL
collagenase type II solution (15-20 min, 22°C). The
collagenase solution was recovered, spun (400xg, 5 min,
22°C), and the pellet was resuspended in M199 media
containing 20% fetal calf serum, 50 μg/mL penicillin/
streptomycin, 2.5 μg/mL fungizone and 2 mM Glutamax-I (20%
media). Cells were seeded onto 12-well collagen-coated plates
or collagen-coated 13 mm coverslips and grown to confluence
in a 5% CO2 incubator at 37°C. Cells were incubated in the
absence or presence of 20-160 µg/ml propolis, or to
isovolumetric solvent (0.26% DMSO) for 90 min at 37°C. Wells
were rinsed with HBSS and then exposed to HBSS containing
10% thiazolyl blue tetrazolium bromide for 2h at 37°C.
Developed formazan crystals in the 12-well plates were
solubilised using MTT Solubilising Solution (Sigma-Aldrich) and
absorbance was measured using a spectrophotometer (Versa
Max, Associates of Cape Cod Int. Inc., Liverpool, UK) at 570
nm. Background readings measured at 690 nm were
subtracted from all values, and cell viability was reported as a
percentage of the media control. Coverslips were mounted
onto glass microscope slides and formazan crystals in cells
were photographed using a brightfield microscope (Olympus
CX31) with camera attachment (Olympus Altra 20 Soft Imaging
System).
Cytosolic and total lactate dehydrogenase (LDH) activity was
measured in the supernatant collected from intact and
solubilised cultured HUVECs using an in vitro LDH activity
assay kit. Briefly, cells were grown to confluence in 12 well
culture plates using 20% M199 media. Media was replaced
with Dulbecco’s phosphate buffer solution and cells were
incubated with propolis (30-160 µg/ml), or isovolumetric
solvents (DMSO or water) for the 160 µg/ml sample of propolis,
for 90 min at 37°C. Some wells were treated with lysis buffer
(1:10 v/v) for 45 min at 37°C to solubilise membranes and allow
determination of total LDH activity. Supernatants were
collected from the wells, and spun at 250xg for 4 min to remove
cellular debris. Samples were incubated with substrate in an
amount equal to twice the volume of medium, for 20 min at
22°C in the dark. Absorbance was read at 490 nm, with
subtraction of non-specific absorbance measured at 690 nm.
LDH leakage was reported as LDH activity in the supernatant,
expressed as a percentage of total cellular LDH activity.
Data analysis
Propolis constituents were quantitated using the Internal
Standard method, as previously described [3]. Concentration-
effect curves were plotted using the Levenberg-Marquardt
fitting routine based on reduction of chi-square (Microcal Origin
Professional V7.5 SR6) and Equation 1.
Equation 1:
Vasodilation (%) =[100 - ((Ytest/YKCl)x100)]%
where Ytest is the response to the sample and YKCl is the
maximal response to 60 mM KCl.
Cell viability for cultured HUVECs was calculated using
Equation 2.
Equation 2:
Viability (%) = ((Atrig/ADMSO)x100)%
where Atrig is the absorbance of cell lysate from cells treated
with T. carbonaria propolis and ADMSO is the absorbance of
cell lysate from cells treated with DMSO.
All values shown in the text and figures are mean±SEM.
Data was compared using Students t- test or one-way ANOVA
with Tukey’s post-hoc test using Windows Prism v. 5.02 and
Microsoft Excel 2000 v. 9.0.2812.
Results
Chemical composition of bee propolis preparations
The chemical composition of propolis samples was
examined using GC-MS analysis. T. carbonaria propolis
contained several isomers of pimaric acid in both extracts and
all subfractions (Table 1). Gallic acid was present in the
methanol and ethanol extracts, and only in the ethyl acetate
fraction (data not shown). Reference compounds of gallic and
pimaric acid conclusively identified these molecules as
constitutents of T. carbonaria propolis. The main constituents
of honeybee propolis from New Zealand tinctures were caffeic
acid derivatives and flavonoids (22.3% w/w), while pimaric and
gallic acids were not detected.
Effects of bee propolis on vascular tone
Baseline vascular tone, and developed tone in vessels pre-
contracted with 60 mM KCl were 46±2 mN (n=6) and 298±47
mN (n=6), respectively. Addition of a single, high concentration
of T. carbonaria propolis (160 µg/ml, 90min) to pre-contracted
vessels reduced tone to near-baseline values (80±12 mN; n=6;
Figure 1A). Propolis (160 µg/ml) also caused a reduction in
Vascular Effects of Stingless Bee Propolis
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tone in porcine coronary arteries that were pre-contracted with
2 mM histamine (Figure 1B), and in human umbilical arteries
that were pre-contracted with 60 mM KCl (Figures 1C, 1E).
Isovolumetric DMSO (0.26%) was without effect (Figures 1D,
1E). The rate of relaxation in pig coronary and human umbilical
arteries following exposure of tissues to propolis was slow (~90
min to reach full relaxation).
The methanolic extract of T. carbonaria propolis (0.8-160
μg/ml) caused concentration-dependent relaxation of 60 mM
KCl-contracted porcine coronary arteries, while isovolumetric
solvent (DMSO, 0.001-0.26%) was without effect (Figure 2A,
B). The potency of the methanolic extract of T. carbonaria
propolis (IC50, 44.7±7.0 µg/ml; n=5) was similar to that of the
ethanolic (IC50, 59.8±19.3 μg/ml; n=3), ethyl acetate (IC50,
34.6±2.7 μg/ml; n=3), and diethyl ether (IC50, 60.9±14.9 μg/ml;
n=3) sub-fractions (Figure 2C, D). The potency of T. carbonaria
propolis preparations was similar to that of the ethanolic
tincture of New Zealand honeybee propolis (71.9±17.1 μg/ml;
n=3) (Figure 2E). Pimaric acid (1-200 µM) and gallic acid
(1-200 µM) reference compounds did not cause a vasorelaxant
Table 1. Chemical composition of T. carbonaria propolis extracts in methanol (MeOH), 96% ethanol (EtOH); fractions in ethyl
acetate (EtOAc) and diethyl ether (Et2O).
Compound MeOH EtOH EtOAc Et2O
Pimaric acid isomer (#18) 0.5±0.0 % 0.3±0.1 % 0.2±0.0 % 0.9±0.1 %
Pimaric acid isomer (#19) 0.3±0.0 % 0.2±0.1 % 0.1±0.1 % 0.9±0.4 %
Pimaric acid (#20) 5.2±0.7 % 3.8±1.4 % 2.0±0.3 % 9.9±0.3 %
Pimaric acid isomer (#29) 8.4±0.6 % 4.5±0.7 % 8.1±5.0 % 1.8±0.2 %
Total pimaranes 14.4±1.2 % 8.8±2.0 % 10.3±5.2 % 13.4±1.0 %
Pimaric acid (Compound #20) was conclusively identified against a commercially available reference. An internal standard method was used for quantitation of constituents
from two independent analyses by GC-MS. Values are mean ±SEM.
doi: 10.1371/journal.pone.0081297.t001
Figure 1.  Original traces showing the effect of Australian stingless bee T. carbonaria propolis on vascular tone in isolated
blood vessel preparations.  Propolis relaxed porcine coronary arteries that were pre-contracted with 60 mM KCl (A), or 2 mM
histamine (B). Propolis relaxed human umbilical arteries that were pre-contracted with 60 mM KCl (C, E; open bar), while the
solvent dimethyl sulfoxide (DMSO) was without effect (D, E; closed bar, n=3, * P<0.05).
doi: 10.1371/journal.pone.0081297.g001
Vascular Effects of Stingless Bee Propolis
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response (92.7±6.8% and 95.5±4.0% of KCl, respectively), with
vascular tone similar to that observed for DMSO (95.9±3.6%;
n=3). The addition of 160 µg/ml propolis to the tissue bath did
not alter the pH of the Krebs Henseleit solution (pH before and
after addition of propolis was 7.6).
After washout of propolis, the response to KCl (developed
tension, 35±12 mN; n=6) was significantly less than the
response to KCl before the addition of propolis (298±47 mN;
n=6; P<0.05). The reversibility of relaxant response to 160
µg/ml propolis was therefore examined over a 6h period in
which tissues were washed and exposed to 60 mM KCl at half-
hourly intervals. The relaxant response was only partially
reversible after 6h washout, with maximal response to KCl in
propolis-treated tissues (56.02±4.13% of pre-treatment KCl
response; n=6) being less than the response to KCl in DMSO-
treated, time-control tissues (84.64±2.83% of pre-treatment KCl
response; n=3; P<0.05) (Figure 3).
Effects of bee propolis on cell morphology and viability
of HUVECs
We examined the possibility that exposure of cells to T.
carbonaria propolis might have caused cytotoxicity leading to
loss of cell viability. Using cultured HUVECs in an MTT cell
toxicity assay, no loss in cell viability was detected when cells
were exposed to T. carbonaria propolis (Figure 4A).
Importantly, similar conditions employed in the tissue bath
experiments were used in the cell viability assay (160 µg/ml
propolis for 90 min at 37°C). Formazan crystals were visualised
in the cytoplasm of the HUVECs using brightfield microscopy
(Figure 4B). Using a toxicity assay that was based on lactate
dehydrogenase activity, some lactate dehydrogenase activity
was detected in the incubation medium (Dulbecco’s phosphate
buffer solution) following exposure of cells to 80 and 160 µg/ml
propolis (Figure 4C). Lower concentrations (20 and 40 µg/ml)
of propolis were without effect. The findings indicate that whilst
mitochondrial function appeared to be preserved in cells that
were exposed to amounts of propolis up to 160 µg/ml propolis,
there was some loss in membrane integrity when propolis was
used at ≥80 µg/ml.
A possible endothelium-dependent mechanism for the
vasorelaxant response to T. carbonaria propolis (40 and 160
µg/ml) was investigated (Figure 5). The relaxant response to
propolis was not attenuated by endothelial cell denudation,
suggesting a direct effect of propolis on the underlying smooth
muscle cells. Successful removal of the endothelial layer was
verified by histological staining of tissue sections taken from
the vessels (data not shown).
To examine the role of voltage-gated Ca2+ channels in the
relaxant response to propolis, vessels were incubated in Ca2+-
free Krebs solution whilst cells were depolarised with 60 mM
KCl to open the voltage-gated Ca2+ channels. In control tissues
incubated with DMSO, Ca2+ caused a maximal response that
was 109.8±14.0% of the response to KCl (EC50 of 0.81±0.19
mM; n=4; Figure 6A-C). The response to Ca2+ in the presence
of propolis was markedly attenuated (20.4±7.4% of the
response to KCl; P<0.05, n=5), with a non-significant trend for
a rightward shift in the response curve (EC50, 2.3±0.69 mM,
n=5). Responses to Ca2+ were inhibited by 10 μM nifedipine.
Propolis was ineffective in relaxing endothelium-denuded
Figure 2.  Effect of Australian stingless bee T. carbonaria propolis and New Zealand honeybee propolis (NZ) on vascular
tone in isolated blood vessel preparations.  A methanolic extract of propolis (0.8-160 µg/ml) produced a dose-dependent
relaxant response in porcine coronary artery rings (A), while solvent (dimethyl sulfoxide, DMSO) was without effect (B).
Concentration effect curves for methanolic (MeOH) and ethanolic (EtOH) extracts of stingless bee propolis (C). Concentration effect
curves for ethyl acetate (EtOAc) and diethyl ether (Et2O) sub-fractions of the methanolic extract of stingless bee T. carbonaria
propolis (D). Concentration effect curves for an ethanolic extract of New Zealand honeybee propolis, and DMSO (E).
doi: 10.1371/journal.pone.0081297.g002
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coronary arteries that were pre-contracted with 100 nM
calyculin A (Figure 6D).
Discussion
In this study we investigated the possible modulation of
vascular tone by Australian stingless bee (T. carbonaria)
propolis. We found that propolis caused a vasorelaxant
response in vessels that were pre-contracted in a receptor-
dependent (histamine) and receptor-independent manner
(KCl), and in vessels sourced from different species (human
and pig). In porcine coronary arteries, the potency of stingless
bee propolis extracts and fractions were similar and in the
range, IC50, 33-63.7 µg/ml. Chemical analysis revealed several
isomeric forms of pimaric acid (Table 1) [3]. We hypothesised
that pimaric acid may elicit a vasorelaxant response in porcine
coronary artery, similar to that reported previously in rat aorta
[21]. However, a reference compound that was identical to
Compound #20 had no effect in our blood vessel preparation.
Whilst this isomer was not responsible for the vasorelaxant
response in the porcine coronary arteries, it comprised only
5.2±0.7% (w/w) of all constituents identified in the methanolic
extract, and we therefore do not exclude the possibility that one
of the other pimaric acid isomers was active.
The potency of stingless bee propolis preparations was not
significantly different to that determined for an ethanolic tincture
of New Zealand honeybee propolis in porcine coronary artery
(IC50, 87.3 µg/ml; this study). Interestingly, the potency of New
Zealand propolis determined in our study was lower than that
determined for an ethanolic extract of Brazilian green propolis
(IC50,15.0 µg/ml) and a flavonoid-rich sub-fraction of that
ethanolic extract (IC50, 4.4 µg/ml) in spontaneously
hypertensive rat aorta [10]. Differences may be related to the
chemical composition of each sample of propolis (botanical
origin), species of animal (pig, rat) and/or tissue type (coronary
artery, aorta).
In this study, the relaxant response to stingless bee propolis
was slow to develop, with maximal effect occurring within 90
min. To our knowledge, no other study has examined the
kinetics for reversibility of the vasorelaxant response to any
Figure 3.  Reversibility of the vasorelaxant response to stingless bee T. carbonaria propolis in 60 mM KCl-precontracted
porcine coronary arteries.  Propolis (160 µg/ml) caused a near-maximal reduction in coronary artery tone within 90 min of
incubation. The contractile response to KCl immediately after washout was markedly lower than the KCl response obtained prior to
addition of propolis (A). The KCl response was not blunted in dimethyl sulfoxide (DMSO)-treated tissues (B). The relaxant response
to propolis was partially reversed during half-hourly wash-KCl cycles over a 6 hour period (open bars, DMSO-treated tissues; closed
bars, propolis-treated tissues (C). W, washout.
doi: 10.1371/journal.pone.0081297.g003
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type of propolis following washout. After exposure of the
coronary artery to stingless bee propolis for 90 min, vascular
tone was reduced to near-baseline values. Following initial
washout of propolis from the bath, addition of 60 mM KCl
produced a contractile effect that was markedly lower than for
KCl when applied prior to the addition of propolis. The findings
suggest that propolis was either toxic to the tissue, or that the
effect of propolis was slowly reversible. Both hypotheses were
examined in this study.
Cell viability in the presence of stingless bee propolis was
examined using an MTT-based in vitro toxicology assay, and a
lactate dehydrogenase activity assay, with conditions that
approximated those used in the tissue bath experiment
(exposure of cells to 160 µg/ml propolis for 90 min at 37°C).
Whilst no loss in cell viability was detected using the MTT
assay using these conditions, some leakage of lactate
dehydrogenase was detected at 80 and 160 µg/ml propolis,
suggesting preserved mitochondrial function but some
deterioration in membrane integrity. Formazan crystals were
visualised in the cytoplasm of the HUVECs, confirming
specificity of the MTT assay. The findings with the MTT assay
are in contrast to previous reports that showed angiogenesis
suppression and chromatic condensation, and disruption of
mitochondrial membrane potential in HUVECs by honeybee
propolis extracts at <50 μg/ml [24-26]. Differences in chemical
composition might contribute to the disparate results. It is
noteworthy, however, that experimental conditions were also
different: 90 min incubation using fed cells in our study
compared to 6-48 h incubation using starved cells in the other
studies. Serum starvation is an established stimulus of
apoptosis [27,28] and autophagy [29], and it is possible that
either of these conditions could have rendered cells more
susceptible to the effects of propolis. This hypothesis is
supported by a study using pancreatic INS-1(β) cells, which
found that fatty acids were not cytotoxic to serum-fed cells, and
only induced apoptosis when cells were ‘fragilized’ by serum
starvation prior to fatty acid exposure [30]. Importantly in our
study, conditions were selected to mimic those used in the
tissue bath experiment.
The possibility that the effects of stingless bee propolis were
slow to reverse was examined by instigating half-hourly wash –
KCl cycles over 6h following attainment of the maximal relaxant
Figure 4.  Cell viability assays.  MTT assay showing cell viability for human cultured umbilical vein endothelial cells (HUVECs)
exposed to stingless bee T. carbonaria propolis or dimethyl sulfoxide (DMSO) for 90 min at 37°C (A). Propolis (20-160 µg/ml) and
isovolumetric DMSO (0.26%) had no effect on cell viability. A punctuate pattern of formazan crystal staining was evident in the
cytoplasm of HUVECs treated with 160 µg/ml propolis for 90 min at 37°C, confirming retention of mitochondrial enzyme activity (B).
Propolis (80 and 160 µg/ml) caused some leakage of lactate dehydrogenase (LDH) into the culture medium (C). Water, DMSO
(0.26%) and propolis (20 and 40 µg/ml) had no effect on LDH leakage.
doi: 10.1371/journal.pone.0081297.g004
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response to propolis. The findings confirmed that the effect of
propolis was slow to reverse. The response to KCl in propolis-
treated tissues increased steadily over the 6h, but remained
lower than the response to KCl in DMSO-treated tissues. The
findings suggest that a longer washout phase would be
required to fully reverse the effects of propolis. However, we
cannot exclude the possibility that this propolis chemotype
contains a compound (or compounds) that partially and
irreversibly relaxes vascular smooth muscle.
Figure 5.  Examination of the role of endothelial cells in the relaxant response to stingless bee T. carbonaria propolis in
porcine coronary arteries.  Propolis (40 and 160 μg/ml) relaxed endothelial-intact (A) and endothelial-denuded coronary arteries
(B). No relaxation was observed in endothelial-intact, time-control tissues treated with DMSO (C). There was no difference in
relaxant response to propolis in endothelial-intact and endothelial-denuded arteries (D), indicating an endothelial-independent
mechanism.
doi: 10.1371/journal.pone.0081297.g005
Figure 6.  Effect of propolis on voltage-gated calcium channels in endothelial-intact porcine coronary arteries.  Arteries
were incubated with 60 mM KCl in calcium-free Krebs solution to depolarise the cells (A-C), or with 100 nM calyculin A in Krebs
solution (D). In the presence of dimethyl sulfoxide (DMSO), arteries produced a concentration-dependent contractile response to
Ca2+ (32 μM-10 mM; A, C). The relaxant response was markedly attenuated in the presence of 160 μg/ml propolis (B, C), and
responses were blocked by the calcium channel inhibitor, nifedipine (Nif., 10 μM; A-C). Propolis was ineffective in relaxing
endothelium-denuded coronary arteries that were pre-contracted with calyculin A (D).
doi: 10.1371/journal.pone.0081297.g006
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We investigated whether an endothelium dependent
mechanism might be important in our observed vasodilator
response. A previous study showed a nitric oxide-dependent
vasorelaxant response to caffeic acid phenethyl ester (CAPE)
[17], a constituent previously identified in honeybee propolis.
However, in our study, CAPE was not detected in stingless bee
propolis. Furthermore, the vasorelaxant response to stingless
bee propolis was unaffected by endothelial denudation. Since
nitric oxide synthase is expressed in endothelial cells and
produces nitric oxide, the findings suggest that stingless bee
propolis might mediate its effects by direct interaction with the
vascular smooth muscle cells. As the response was observed
in vessels that were pre-contracted with a high concentration of
KCl (60 mM), mechanisms involving potassium efflux are
unlikely [31]. A possible mechanism involves inhibition of
voltage-gated calcium channels in the smooth muscle by
propolis, similar to that previously reported for NaHS in mouse
aorta [32]. To test this hypothesis, we constructed
concentration-effect curves to Ca2+, in the presence or absence
of propolis, in Ca2+-free Krebs solution. The findings showed
marked attenuation in the contractile response to Ca2+ by
propolis when cells were depolarized with potassium.
The role of myosin light chain phosphatase in the
dephosphorylation of myosin light chain, leading to vascular
relaxation is well established [33]. We speculated that if
propolis was mediating its vasorelaxant effect through
stimulation of myosin light chain phosphatase, it would not be
able to reverse a contractile response to a myosin light chain
phosphatase inhibitor. We found that propolis was able to relax
vessels pre-constricted with histamine and KCl, but was
ineffective against calyculin A. Further studies are required to
examine this possible mechanism in further detail, including
effects on RhoA-dependent signalling pathways.
In conclusion, this study has identified a marked
vasorelaxant response to Australian stingless bee T.
carbonaria propolis in KCl- and histamine-precontracted
porcine isolated coronary arteries. The response was
endothelium-independent. We showed that a contractile
response to Ca2+ in potassium depolarised vessels incubated in
Ca2+-free Krebs solution was markedly attenuated by propolis.
The findings suggest a mechanism involving inhibition of
voltage-gated Ca2+ channels. Under the experimental
conditions used in this study, high concentrations (80 and 160
µg/ml) propolis caused some loss in membrane integrity, but no
apparent loss in mitochondrial function. The relaxant response
was slowly and partially reversible upon washout. We suggest
that Australian stingless bee propolis may have therapeutic
potential for management of cardiovascular disorders involving
compromised vascular supply, although safety testing is
warranted.
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